Back
Corbus Pharmaceuticals Holdings Vs. Panbela Therapeutics Industry Stock Comparison
Buy
59
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
42.32
Seasonality Move:
-13.76%
Sell
13
PBLA
Panbela Therapeutics
Last Price:
0.38
Seasonality Move:
-18.15%
Buy
59
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $39.65. The Score for CRBP is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
13
Panbela Therapeutics (PBLA)
is a Sell
Is Panbela Therapeutics a Buy, Sell or Hold?
- The current Panbela Therapeutics [PBLA] share price is $0.38. The Score for PBLA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- PBLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $39.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRBP is experiencing slight buying pressure.
PBLA Stock Price Chart
What is Panbela Therapeutics's stock price today?
-
The Panbela Therapeutics share price today is $0.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBLA is experiencing selling pressure, which indicates risk of future bearish movement.
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 56.32 | Buy |
| Chaikin Money Flow: | 67513 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.1 - 40.28) | Buy |
| Bollinger Bands (100): | (12.07 - 39.97) | Buy |
PBLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 33.06 | Sell |
| Chaikin Money Flow: | -10963 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.41 - 0.55) | Sell |
| Bollinger Bands (100): | (-2.24 - 11.3) | Sell |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.45 | Buy |
| 20-day SMA: | 37.99 | Buy |
| 50-day SMA: | 38.04 | Buy |
| 200-day SMA: | 16.01 | Buy |
| 8-day EMA: | 38.1 | Buy |
| 20-day EMA: | 37.78 | Buy |
| 50-day EMA: | 35.17 | Buy |
| 200-day EMA: | 21.01 | Buy |
PBLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.41 | Sell |
| 20-day SMA: | 0.46 | Sell |
| 50-day SMA: | 0.64 | Sell |
| 200-day SMA: | 13.63 | Sell |
| 8-day EMA: | 0.41 | Sell |
| 20-day EMA: | 0.47 | Sell |
| 50-day EMA: | 1.35 | Sell |
| 200-day EMA: | 708.38 | Sell |
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.66 per share, and an increase next year of $0.09 per share.
Panbela Therapeutics Earnings Growth & PBLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $39.91 per share, a decrease next quarter of $0.00 per share, an increase this year of $2,223.30 per share, and a decrease next year of $0.36 per share.
Corbus Pharmaceuticals Holdings Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Panbela Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||